Archive | Innovator’s Pitch Challenge RSS feed for this section

RESI Boston IPC Finalists

1 Sep

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claireThe RESI Boston, September 21-23, Innovator’s Pitch Challenge (IPC) finalists are in! The IPC will include 14 sessions for finalist companies to pitch to a judging panel featuring investors and strategic partners. In addition, each company will be presenting a posterboard in the RESI exhibit hall throughout the conference. All RESI attendees will be given 5 pieces of “RESI Cash,” which can be used to “invest” or vote for their favorite companies, and the Top 3 companies with the highest number of votes will be announced at the end of RESI with a prize and newsletter feature.

Participating in the IPC is an unparalleled opportunity for actively fundraising startups to boost their exposure and engage a wider network of global investors and strategic partners.

See all pitching companies:

Interested in learning more about these companies? The RESI partnering system just opened on Monday – it is not too late to register for RESI and engage with IPC finalists and 700+ attendees who will be attending RESI. Sign up here!


RESI Boston Pitch Applications Now Open

23 Jun

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN


One of the best parts of RESI returning to an in-person format after more than two years is the return of the live pitch session! RESI Boston returns in-person September 21-22, with an additional day of dedicated-digital partnering September 23. Applications to pitch for the Innovator’s Pitch Challenge (IPC) are now open until Friday, August 12! The IPC was created to respond to the need for a digital pitch format. Now it has been modified to bring the value and function to an in-person format.

What Is It?
The Innovator’s Pitch Challenge (IPC) is an opportunity for early-stage life science and healthcare companies to gain additional exposure to conference attendees and pitch directly to a panel of judges, featuring active investors and industry experts. Participating companies pay to host their company materials on the Live Agenda and participate in the live pitch session.

How Does It Work?
Pitching companies will have a dedicated webpage on the RESI Live Agenda, which greatly increases visibility to investors and other registered attendees. Companies can share their marketing collateral such as their slide deck, executive summary, optional pitch video, and more.

Each pitching company will be assigned to an IPC session, with each session featuring four companies, grouped together based on similar sector and/or technology. Companies will be given four minutes to pitch, followed by an additional ten minutes of Q&A and feedback from the judging panel.

Who Should Apply?
Early-stage life science companies actively raising seed capital ($25K – 2M), Series A ($2 – 10M), or Series B ($10 – 50M) use the IPC to get in front of the panel of qualified investor judges in their market segment and pitch their company and product. Early-stage companies are encouraged to apply and submit their pitch deck and executive summary.


RESI-Boston-2022-Banner - new - 1100px

Digital RESI June IPC Winners

16 Jun

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN


At Digital RESI June, nearly 50 life science and healthcare startups participated in the Innovator’s Pitch Challenge (IPC), a unique pitching opportunity for early-stage companies in therapeutics, medical device, diagnostics, digital health, and R&D/services sectors.

All attendees are encouraged to participate in viewing each finalist’s dedicated webpage, pitching materials, and live session in order to vote for the best pitch at RESI. Everyone from fellow startup founders to active early-stage investors votes for their favorite companies based on the materials displayed on their dedicated landing pages (pitch video, slide deck, executive summary, etc.) as well as their performance in live Q&A sessions, in which founders pitch directly to and participate in a subsequent Q&A with investor judges.

Life Science Nation is pleased to share the winners of last week’s IPC who received the most votes during the 3-day conference. Congratulations to the winners! Check them out below and see the full list of finalists. The IPC returns to an in-person format September 21-22 at RESI Boston! Contact us to learn more and apply.

Surgical Automations, Inc. – First Place
We are building the Tesla for endoscopic procedures. We are developing Automated Endoscopic Robots for procedures such as Upper and Lower GI endoscopy, Cystoscopy and Ureteroscopy, Endotracheal Intubation and Bronchoscopy. Our core technology is AI based Automated Robotic Endoluminal Navigation (AREN) and is supplemented by an IoT infrastructure that enables us to offer an integrated stakeholder experience to patients, physicians and the hospital leadership. The automated scanning of the anatomy is performed in a predetermined fashion ensuring all areas are visualized. During scanning, our AI/ML algorithms that are developed after extensive training on the images, identify the target anatomy and screen for any visual abnormality. If identified and when indicated, the robot will recommend the procedure to perform. Upon confirmation from the physician, the robot will mark a trajectory on the lesion predicting the exact location where the intervention will be done. Upon confirmation from the physician, the robot will perform the procedure. All this is automated and done under the supervision of the physician who has the capability to manually override at any time. Additionally, in addition to providing us with important data for business analytics, the IoT infrastructure and data warehouse also offers value-added interactive interfaces to our stakeholders for a superior experience and engagement.

JOCAVIO Co. Ltd. – Second Place
JOCAVIO Co. Ltd. was founded in 2021 by Drs. Tomoko and Hiroyuki Inoue together with seasoned industry experts in 2021 with a vision to provide “Hope for the Irreplaceable Lives of Cancer Patients”. JOCAVIO’s core expertise is genetic manipulation of vaccinia virus and the unique coating technology that enable repeated systemic administration of virus vectors. Moreover, we utilize a promising nanobody technology that allows multi-epitope binding for cancer specific tropism. Our primary focus is a novel oncolytic virus that provides not only robust efficacy with multiple targets but also possesses a “kill switch” that inhibits virus replication in case of excess activity. Utilizing our expertise on vaccinia virus, we have a project on SARS-Cov-2 vaccine that would be effective regardless of different variants. This project is an expedited project in needs of effective vaccines and will enter FIH in 3Q 2023 and we expect to complete P2 in 2024. Similarly, some early pipelines in consideration include vaccines that are effective for Zika and Dengue fever. We are looking for investors to help us in seed finance to support FIH in 2024-2025. Also we are keen on a strategic partnership with companies who are interested in co-development of our vaccine projects in APAC countries.

SynCell Biotechnology, Inc. – Third Place
SynCell’s business is focused on making the cutting edge a reality, offering a pipeline of novel antimicrobial products from our patented platform that improves patients’ quality of life, enhances the quality of care, and reduces the burden on society from the costs of antimicrobial resistance.


RESI-Boston-2022-Banner - new - 1100px

Digital RESI June Pitch Finalists

26 May

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN


Congratulations to the Digital RESI June Innovator’s Pitch Challenge (IPC) finalists! Applications came in from companies representing various sectors: therapeutics, medical devices, diagnostics, digital health, and R&D services. These companies will present at the upcoming conference and will each have a dedicated landing page showcasing their product and technology. Each finalist is assigned to a live Q&A session featuring a panel of investors and industry experts who actively seek to work and partner with early-stage innovations.

Companies participating in the IPC have constantly received positive feedback from our investor network due to their high quality of presentation and ability to answer high-level questions, among other positive elements. These sessions have been valuable for the participating companies in being able to connect with relevant investors, and we look forward to another great round of presentations and engaging Q&A from this group. Learn more about each finalist below.

Are you interested in showcasing your startup to early-stage investors at RESI Boston, September 21-22? Contact our business development team to discuss the IPC format and to see if you are a fit!

Want to learn more? The Business Development team at Life Science Nation is available to answer questions and share additional details to help you meet your partnership goals!
East Coast (USA) & China
Midwest (USA)
& Canada
West Coast  (USA)
Greg Mannix
Vice President International Business Development
Book a Meeting
Email Me
Candice He
VP, Business Development & Global Investment Strategist
Book a Meeting
Email Me
Antoinette Lowre
Manager of Business Development
Book a Meeting
Email Me
Alexander Vassallo
Manager of Business Development
Book a Meeting
Email Me

The Story of Innovator’s Pitch Challenge

12 May

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN


Just as a good story is the backbone to any pitch, so the story behind the Innovator’s Pitch Challenge (IPC) explains why it has become a RESI mainstay and one of the event’s most popular sessions with both startups and investors alike. Prior to the Covid-19 global pandemic, pitch sessions were included in the RESI agendas, but not met with the same enthusiasm we now see. In early 2020, the entire life science industry scrambled to figure out how to best adjust and shift perspectives and workflow.

As the world came to a halt, RESI had to pivot, and we reassessed how to best add value to the growing need for early-stage technology assets in life science and healthcare. Pitching is necessary for startups to share their story and increase their exposure to investors and other relevant industry experts. However, there is often a noticeable lack of engagement. At other conferences, we saw companies that had dedicated hours and days to practicing and perfecting their pitch got little value-add beyond the single encounter. Adding this value to a virtual format became our singular goal.

The IPC is unique in that all companies have a dedicated landing page where they can share any relevant company materials, viewable by all conference attendees. All IPC finalists are assigned to a live Q&A session with investor and industry expert judges who actively work with companies in their sector and stage of development and receive early access to each company’s marketing materials, which allows for more targeted, detailed questions. These judges often self-select, so they participate with genuine interest in the participating companies. See what judges have had to say about their participation:

“The Pitch Sessions were a great opportunity to engage with the CEO/Founders of very innovative Life Science startups. Despite the COVID-related transition from in-person to virtual meetings, the RESI team did an outstanding job organizing these sessions, ensuring that the live Q&A was very productive, and facilitating follow-up with these exciting companies.”

Gary Gershony, Life Science Angels / BayMed Venture Partners


“The Pitch Sessions are a great opportunity to connect with startup CEOs and learn more about their work…It really has been an effective and efficient way to make connections, create deal flow and help startups raise money for their upcoming raises.”

Mayank Taneja, OSF Healthcare

“It was a very economical use of time; the investors got to ask their important questions and the Innovators got a good idea of the most pressing questions from the investors point of view.”

William Kuziel, MedPro Investors
To date, 700+ companies applied to present and 300+ unique investors and industry expert judges have participated in the live pitch sessions. Join the companies featured below and apply to pitch at Digital RESI, June 7-9 by Friday, May 13!

400 Reasons to Not Miss Out

5 May

By Greg Mannix, Vice President International Business Development, General Manager Europe, LSN

Are you looking for early-stage investors? Digital RESI, June 7-9 is the (virtual) place to be! Don’t take my word for it, though. Check out the investors and strategic partners who are already registered for Digital RESI June and decide for yourself how you want to connect with 400+ top early-stage investors and strategics. You can book meaningful meetings with the right players on the powerful RESI Partnering Platform, and you still have a chance to compete in the Innovator’s Pitch Challenge. Be sure to register by this Friday, May 6 to save $200 on registration.

Confirmed Investors and Strategic Partners*

*As of May 4, 2022


Building the Perfect Pitch

5 May

By Karen Deyo, Director of Investor Research, Israel BD, LSN

A perfectly honed pitch is an important part of a startup’s bag of tricks. Many think that having a good pitch is easy because no one knows their company better than they do, and telling people about it is simple enough, right? Wrong! Building a concise pitch with the right amount of information to tell enough of the story to catch an investor’s attention can be a long and arduous process. When working with some of our branding and messaging clients, the elevator pitch can go through dozens of drafts before finding the right balance.

A good pitch should give investors a snapshot of your technology, your stage of development, what makes your technology unique, what you are looking to raise and what milestones you are looking to achieve. Some companies may also choose to highlight any relevant experience with the management team, the involvement of a KOL, or maybe a key partnership that they have developed. Each elevator pitch is unique, depending on the company and what part of their story is crucial to highlight. The one thing that all pitches have in common is that they take a lot of practice to perfect. However, you cannot practice in a vacuum – getting solid feedback is a critical part of developing a solid pitch.

This is where pitch sessions, like RESI’s Innovator’s Pitch Challenge (IPC) come in. The IPC provides a chance to hone your pitch, practice pitches in different lengths, from the 4-minute prerecorded pitch to the 1-minute live pitch during the Q&A session and get a glimpse of what questions an investor may ask for clarification. Participating in pitch sessions like the IPC gives you a glimpse into what questions investors are frequently asking you. This may indicate an area of your pitch that needs more work, or a part of your company strategy that you should develop more fully to appeal to more investors. Joining the IPC is a wonderful tool to help you make a great first impression.

Join Life Science Nation for a FREE Bootcamp in preparation for the Innovator’s Pitch Challenge.

Tuesday, May 10, 11AM EDT
Preparing to Pitch at RESI 
  • Greg Mannix, Vice President International Business Development, General Manager Europe, Life Science Nation
The Innovator’s Pitch Challenge (IPC) is an opportunity for early-stage companies to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session. This bootcamp will walk through the process of preparing your pitch materials and what to expect in a live pitch session, including frequently asked questions from investor judges.

The application deadline for the IPC has been extended, so it’s not too late to apply for the IPC for Digital RESI June – apply here!

%d bloggers like this: